Ampio Pharmaceuticals, Inc. (NYSEMKT:AMPE) went lower by -61.14% to close at $ 1.29. The company exchanged total volume of 14.49 million shares throughout course of last trade however it holds an average trading capacity of 339.31 thousand shares. Shares of company began trading at $0.98 climbed to high of $1.54 touched the low of $0.84.
The company is trading below its 50-day moving averages of 3.69 and down from 200-day moving averages of 3.02. The firm has price to book ratio of 9.62 and its price to sale ratio was 148.56.
Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) reported the results of the Ampion™ PIVOT clinical trial as well as a comprehensive analysis that integrates trial data from three single injection studies that will be presented to the FDA.
Ampio Pharmaceuticals, Inc.’s (AMPE) has price-to-cash ratio of 6.05 and price to sale ratio of 61.02. The company gross profit margin is 67.60%. A look on the firm performance, its monthly performance is -65.96% and a quarterly performance of -51.32%. The stock price is moving down from its 20 days moving average with -63.68% and isolated negatively from 50 days moving average with -66.04%.
Relypsa, Inc. (NASDAQ:RLYP) surged +3.24% and closed the trade at $ 18.50. The company recorded a trading capacity of 1.92 million shares below its three months average daily volume of 3.17 million shares. During the last trade, shares reached to high price of $18.73 and touched the low price of $17.61. The stock’s 50-day moving average is noted at $17.32 and its 200-day moving average is stands at $18.29.
Additionally, the company has EPS of -4.84. The company has market capitalization of $827.82M.
The average true range of Relypsa, Inc.’s (RLYP) is recorded at 1.35 and the relative strength index of the stock stands 52.85. The stock price is going above to its 52 week low with 80.31% and lagging behind from its 52 week high with -48.57%. Analyst recommendation for this stock stands at 1.70. A look on the firm performance, its monthly performance is -6.85% and a quarterly performance of 39.10%. The stock price is trading downbeat from its 200 days moving average with -2.05% and up from 50 days moving average with 7.64%.